Cleared Traditional

K112141 - SMARTEPIL,DEPILASE YAG LASE PLUS

K112141 is an FDA 510(k) clearance for SMARTEPIL, manufactured by Castle Laser Systems, Limited. The device is a Class 2 General & Plastic Surgery device with product code GEX cleared through the Traditional 510(k) pathway after a 262-day FDA review.

K112141 · Castle Laser Systems, Limited · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2012
Decision
262d
Days
Class 2
Risk

K112141 is an FDA 510(k) clearance for the SMARTEPIL,DEPILASE YAG LASE PLUS. Classified as Powered Laser Surgical Instrument within the GEX classification (a category for powered laser surgical instruments across multiple specialties), Class II - Special Controls.

Submitted by Castle Laser Systems, Limited (Chatham, US). The FDA issued a Cleared decision on April 13, 2012 after a review of 262 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Castle Laser Systems, Limited devices

FDA 510(k) Submission Details - K112141

510(k) Number K112141 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 26, 2011
Decision Date April 13, 2012
Days to Decision 262 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
147d slower than avg
Panel avg: 115d · This submission: 262d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GEX Device Classification - Class 2, Special Controls

Product Code GEX Powered Laser Surgical Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition A Laser (light Amplification By Stimulated Emission Of Radiation) Based Device Having Coherence, Collimated And Typically Monochromatic Radiation. Typically Indicated To To Cut, Destroy, Remove Or Coagulate Tissue, Generally Soft Tissue, For General Surgical Purpose In Medical Specialties Of General And Plastic Surgery, Dermatology/aesthetic, Podiatry, Otolaryngology (ent), Gynecology, Neurosurgery, Orthopedics (soft Tissue), Dental And Oral Surgery, And Dentistry. The Classification Regulation 21 Cfr 878.4810 Describes A Device That Is Carbon Dioxide Or Argon Laser Intended To Cut, Destroy, Remove Or Coagulate Tissue By The Light.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GEX Powered Laser Surgical Instrument

All 1754
Devices cleared under the same product code (GEX) and FDA review panel - the closest regulatory comparables to K112141.
PALOMAR VECTUS LASER
K120622 · Palomar Medical Technologies, Inc. · May 2012
SIDELAZE LASER BEAM DELIVERY ACCESSORY FOR CYNOSURE 1440NM WAVELENGTH LASERS
K121127 · Cynosure, Inc. · May 2012
TATTOOSTAR EFFECT Y
K112669 · Asclepion Laser Technologies GmbH · May 2012
ADVANTAGE LASER SYSTEM
K113502 · Lutronic Corporation · Apr 2012
SPECTRA LASER SYSTEM
K113588 · Lutronic Corporation · Feb 2012
ANGIODYNAMICS, INC. VENACURE NEVERTOUCH DIRECT PROCEDURE KIT
K112600 · AngioDynamics, Inc. · Jan 2012